Having trouble accessing articles? Reset your cache.

Pomalidomide: Phase II data

A Phase II trial in 70 patients with MM refractory to both Revlimid lenalidomide and Velcade bortezomib showed that

Read the full 198 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE